Placeholder Banner

BIO Announces IAR – The French Bioeconomy Cluster as a Key Supporting Organization of the 2016 BIO World Congress on Industrial Biotechnology

April 4, 2016

Washington, D.C. (April 04, 2016) The Biotechnology Innovation Organization (BIO) is pleased to announce that Europe’s largest cluster of bioeconomy companies, IAR, will be a top supporting organization of BIO’s 13th Annual World Congress on Industrial Biotechnology. IAR represents more than 300 innovative companies and technology developers who produce biofuels and biobased products from agricultural residue and biomass. At this year’s conference, IAR will sponsor 400 square feet of Exhibit Space and panel a Breakout Session. The world’s largest industrial biotechnology event will be held April 17-20, 2016 at the San Diego Convention Center in San Diego, CA.

“We are pleased that one of the largest technology incubators in Europe will be a supporting organization for the 2016 BIO World Congress on Industrial Biotechnology,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Section. “Attendees will be able to meet and hear directly from IAR representatives on what the industry is doing in Europe to reduce our dependence on fossil fuels and help grow the bioeconomy.”

“As the European cluster reference dedicated to the bioeconomy, IAR is pleased to collaborate this year again with BIO,” said Boris Dumange, Director General of IAR. “With more than 25 people in this year’s IAR’s delegation to the BIO World Congress on Industrial Biotechnology, the event is a unique opportunity to meet with the French bioeconomy community and discuss potential collaborations and partnerships,” Dumange concluded.

On Monday, April 18, 2016, IAR will co-host a Breakout panel as part of the Advanced Biofuels and Biorefinery Platforms Track. Titled “Filling the Gap from Labscale to Commercialization: De-risking Investments and Reducing Time to Market,” panelists will discuss what is required for companies to successfully bring pilot projects to commercialization. Potential prerequisites to be addressed include efficient equipment, securing investors, and skilled workers who specialize in managing the interface between metabolic engineering and bio process engineering.

The panel will be moderated by Olivier Rolland of Total New Energies USA, Inc. and include:

  • Christophe Luguel, IAR
  • Guy Helin, Syngulon
  • Jean Christophe Duval, ARD
  • Pascal Rousseaux, Processium

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference, please visit For assistance, please contact

About IAR

IAR is the French cluster dedicated to the Bioeconomy. It brings together more than 300 stakeholders from farmer cooperatives to research organisations, universities, VCs, start-up, SMEs and large industries, including end-users, around a common goal: the optimal valorisation of renewable resources. IAR’s strategic axis are: bio-based chemicals, biomaterials, advanced biofuels and biogas, ingredients for food and feed as well as renewable resources.


About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

    Discover More
    Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
    "What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
    The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…